Antigen presentation by cardiac fibroblasts promotes cardiac dysfunction

N Ngwenyama, K Kaur, D Bugg, B Theall… - Nature cardiovascular …, 2022 - nature.com
N Ngwenyama, K Kaur, D Bugg, B Theall, M Aronovitz, R Berland, S Panagiotidou, C Genco…
Nature cardiovascular research, 2022nature.com
Heart failure (HF) is a leading cause of morbidity and mortality. Studies in animal models
and individuals with HF revealed a prominent role for CD4+ T cell immune responses in the
pathogenesis of HF and highlighted an active cross-talk between cardiac fibroblasts and
interferon (IFN)-γ-producing CD4+ T cells that results in profibrotic myofibroblast
transformation. Whether cardiac fibroblasts concomitantly modulate pathogenic cardiac
CD4+ T cell immune responses is unknown. Here we report that mouse cardiac fibroblasts …
Abstract
Heart failure (HF) is a leading cause of morbidity and mortality. Studies in animal models and individuals with HF revealed a prominent role for CD4+ T cell immune responses in the pathogenesis of HF and highlighted an active cross-talk between cardiac fibroblasts and interferon (IFN)-γ-producing CD4+ T cells that results in profibrotic myofibroblast transformation. Whether cardiac fibroblasts concomitantly modulate pathogenic cardiac CD4+ T cell immune responses is unknown. Here we report that mouse cardiac fibroblasts express major histocompatibility complex type II (MHCII) in two different experimental models of cardiac inflammation. We demonstrate that cardiac fibroblasts take up and process antigens for presentation to CD4+ T cells via MHCII induced by IFN-γ. Conditional deletion of MhcII in cardiac fibroblasts ameliorates cardiac remodeling and dysfunction induced by cardiac pressure overload. Collectively, we demonstrate that cardiac fibroblasts function as antigen-presenting cells and contribute to cardiac fibrosis and dysfunction through MHCII induced by IFN-γ.
nature.com